Adult cell therapy for brain neuronal damages and the role of tissue engineering

Biomaterials

Volumn 31, Issue 8, 2010, Pages 2105-2120

  Delcroix, Gaëtan J R ^a,b   Schiller, Paul C ^c,d   Benoit, Jean Pierre ^a,b   Montero Menei, Claudia N ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adult cells; Biomimetic surface; Brain disorders; Mesenchymal stromal cells; Pharmacologically active microcarriers; Scaffolds

Indexed keywords

BIOMIMETIC SURFACES; BRAIN DISORDERS; MESENCHYMAL STROMAL CELLS; MICROCARRIERS; PHARMACOLOGICALLY ACTIVE MICROCARRIERS;

ALDEHYDES; BIOMIMETICS; BRAIN; CELL PROLIFERATION; DRUG PRODUCTS; GRAFTING (CHEMICAL); GRAFTS; SCAFFOLDS; TISSUE; TISSUE ENGINEERING;

STEM CELLS;

ALGINIC ACID; MOLECULAR SCAFFOLD; POLYGLACTIN;

ADRENAL CELL; ADULT; BRAIN DISEASE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CHEMICAL MODIFICATION; CHROMAFFIN CELL; CLINICAL TRIAL; DEGENERATIVE DISEASE; EMBRYO CELL; EXTRACELLULAR MATRIX; FETUS CELL; GEL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL LESION; NEURAL STEM CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVIEW; STROKE; STROMA CELL; TISSUE ENGINEERING; TRAUMATIC BRAIN INJURY;

ADULT STEM CELLS; ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN; BRAIN INJURIES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EXTRACELLULAR MATRIX; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; STROKE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE THERAPY;

EID: 74449086728     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.084     Document Type: Review

References (204)

1. Kuroyanagi Y., Kubo K., Matsui H., Kim H.J., Numari S., Mabuchi Y., et al. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 28 (2004) 13-21
2. Langlois J.A., Kegler S.R., Butler J.A., Gotsch K.E., Johnson R.L., Reichard A.A., et al. Traumatic brain injury-related hospital discharges. Results from a 14-state surveillance system. 1997. MMWR Surveill Summ 52 (2003) 1-120
3. Cohen S. La maladie de Parkinson en Europe: Quel poids économique?. Neurologies 9 (2006) [in French]
4. Kim S.U., and de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res (2009)
5. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
6. Hatcher J.M., Pennell K.D., and Miller G.W. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29 (2008) 322-329
7. Brassat D., Durr A., Agid Y., and Brice A. [Genetics of Parkinson disease]. Rev Med Interne 20 (1999) 709-714
8. Spacey S.D., and Wood N.W. The genetics of Parkinson's disease. Curr Opin Neurol 12 (1999) 427-432
9. Lesage S., and Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18 (2009) R48-R59
10. Papa S.M., Engber T.M., Kask A.M., and Chase T.N. Motor fluctuations in levodopa treated Parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 662 (1994) 69-74
11. Fahn S. Is levodopa toxic?. Neurology 47 (1996) S184-S195
12. Walter B.L., and Vitek J.L. Surgical treatment for Parkinson's disease. Lancet Neurol 3 (2004) 719-728
13. Koller W.C., Pahwa R., Lyons K.E., and Albanese A. Surgical treatment of Parkinson's disease. J Neurol Sci 167 (1999) 1-10
14. Brundin P., Barbin G., Isacson O., Mallat M., Chamak B., Prochiantz A., et al. Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neurosci Lett 61 (1985) 79-84
15. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., and Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 5 (1999) 97-100
16. Brundin P., Karlsson J., Emgard M., Schierle G.S., Hansson O., Petersen A., et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transpl 9 (2000) 179-195
17. Isacson O., Bjorklund L.M., and Schumacher J.M. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol 53 Suppl. 3 (2003) S135-S146 [discussion S46-8]
18. Olanow C.W., Schapira A.H., and Agid Y. Neuroprotection for Parkinson's disease: prospects and promises. Ann Neurol 53 Suppl. 3 (2003) S1-S2
19. Drucker-Colin R., and Verdugo-Diaz L. Cell transplantation for Parkinson's disease: present status. Cell Mol Neurobiol 24 (2004) 301-316
20. Stover N.P., and Watts R.L. Spheramine for treatment of Parkinson's disease. Neurotherapeutics 5 (2008) 252-259
21. Cherksey B.D., Sapirstein V.S., and Geraci A.L. Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 75 (1996) 657-664
22. Borlongan C.V., Saporta S., and Sanberg P.R. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiParkinsonian rats. Exp Neurol 151 (1998) 203-214
23. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: the International Society for cellular therapy position statement. Cytotherapy 7 (2005) 393-395
24. Eglitis M.A., and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94 (1997) 4080-4085
25. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., and Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31 (2003) 890-896
26. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5 (2003) 485-489
27. Maitra B., Szekely E., Gjini K., Laughlin M.J., Dennis J., Haynesworth S.E., et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33 (2004) 597-604
28. Nasef A., Mathieu N., Chapel A., Frick J., Francois S., Mazurier C., et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84 (2007) 231-237
29. Gotherstrom C., Ringden O., Tammik C., Zetterberg E., Westgren M., and Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190 (2004) 239-245
30. Hermann A., Maisel M., and Storch A. Epigenetic conversion of human adult bone mesodermal stromal cells into neuroectodermal cell types for replacement therapy of neurodegenerative disorders. Expert Opin Biol Ther 6 (2006) 653-670
31. Ross J.J., and Verfaillie C.M. Evaluation of neural plasticity in adult stem cells. Philos Trans R Soc Lond B Biol Sci 363 (2008) 199-205
32. Song S., and Sanchez-Ramos J. Brain as the sea of marrow. Exp Neurol 184 (2003) 54-60
33. Tatard V.M., D'Ippolito G., Diabira S., Valeyev A., Hackman J., McCarthy M., et al. Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 40 (2007) 360-373
34. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 (1999) 10711-10716
35. Zhao L.R., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., and Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174 (2002) 11-20
36. Jendelova P., Herynek V., Urdzikova L., Glogarova K., Kroupova J., Andersson B., et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 76 (2004) 232-243
37. Delcroix G.J., Jacquart M., Lemaire L., Sindji L., Franconi F., Le Jeune J.J., et al. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res 1255 (2009) 18-31
38. Mahmood A., Lu D., Wang L., and Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 19 (2002) 1609-1617
39. Sykova E., and Jendelova P. In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res 161 (2007) 367-383
40. Hellmann M.A., Panet H., Barhum Y., Melamed E., and Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 395 (2006) 124-128
41. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 105 (2008) 14638-14643
42. Zhang J., Li Y., Chen J., Cui Y., Lu M., Elias S.B., et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195 (2005) 16-26
43. Chen X., Li Y., Wang L., Katakowski M., Zhang L., Chen J., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22 (2002) 275-279
44. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59 (2002) 514-523
45. Bang O.Y., Lee J.S., Lee P.H., and Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57 (2005) 874-882
46. Lois C., and Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 90 (1993) 2074-2077
47. Garcia-Verdugo J.M., Doetsch F., Wichterle H., Lim D.A., and Alvarez-Buylla A. Architecture and cell types of the adult subventricular zone: in search of the stem cells. J Neurobiol 36 (1998) 234-248
48. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10 Suppl. (2004) S42-S50
49. Pagano S.F., Impagnatiello F., Girelli M., Cova L., Grioni E., Onofri M., et al. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18 (2000) 295-300
50. Zhao M., Momma S., Delfani K., Carlen M., Cassidy R.M., Johansson C.B., et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 100 (2003) 7925-7930
51. Roy N.S., Wang S., Jiang L., Kang J., Benraiss A., Harrison-Restelli C., et al. In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med 6 (2000) 271-277
52. Arias-Carrion O., and Yuan T.F. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?. Med Hypotheses (2009)
53. Tatard V.M., Menei P., Benoit J.P., and Montero-Menei C.N. Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach. Curr Drug Targets 6 (2005) 81-96
54. Orive G., Anitua E., Pedraz J.L., and Emerich D.F. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci (2009)
55. Bible E., Chau D.Y., Alexander M.R., Price J., Shakesheff K.M., and Modo M. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials (2009)
56. Li Y., and Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett 456 (2009) 120-123
57. Li Y., Chopp M., Chen J., Wang L., Gautam S.C., Xu Y.X., et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20 (2000) 1311-1319
58. Chen J., Li Y., Wang L., Lu M., Zhang X., and Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189 (2001) 49-57
59. Mezey E., Chandross K.J., Harta G., Maki R.A., and McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (2000) 1779-1782
60. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., and Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A 100 (2003) 1364-1369
61. Esneault E., Pacary E., Eddi D., Freret T., Tixier E., Toutain J., et al. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (2008)
62. England T. Stem cells for enhancing recovery after stroke: a review. Int J Stroke 4 (2009) 101-110
63. Tang Y., Pacary E., Freret T., Divoux D., Petit E., Schumann-Bard P., et al. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 21 (2006) 18-28
64. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73 (2003) 778-786
65. Wang L., Chopp M., Zhang R.L., Zhang L., Letourneau Y., Feng Y.F., et al. The notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke. Neuroscience (2008)
66. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49 (2005) 407-417
67. Chopp M., Li Y., and Zhang J. Plasticity and remodeling of brain. J Neurol Sci 265 (2008) 97-101
68. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92 (2003) 692-699
69. Chen J., and Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3 (2006) 466-473
70. Re D.B., and Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nat Neurosci 9 (2006) 859-861
71. Madrigal J.L., Leza J.C., Polak P., Kalinin S., and Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 29 (2009) 263-267
72. Chen X., Katakowski M., Li Y., Lu D., Wang L., Zhang L., et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69 (2002) 687-691
73. Richardson R.M., Sun D., and Bullock M.R. Neurogenesis after traumatic brain injury. Neurosurg Clin N Am 18 (2007) 169-181 [xi]
74. Yang K.L., Chen M.F., Liao C.H., Pang C.Y., and Lin P.Y. A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy. Cytotherapy (2009) 1-12
75. De Keyser J. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 58 (2005) 653-654 [author reply 4-5]
76. Lindvall O., and Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30 (2009) 260-267
77. Chen C.W., Boiteau R.M., Lai W.F., Barger S.W., and Cataldo A.M. sAPPalpha enhances the transdifferentiation of adult bone marrow progenitor cells to neuronal phenotypes. Curr Alzheimer Res 3 (2006) 63-70
78. Wu Q.Y., Li J., Feng Z.T., and Wang T.H. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model. Neurosci Lett 417 (2007) 281-285
79. Lee J.K., Jin H.K., and Bae J.S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci Lett 450 (2009) 136-141
80. Deckel A.W., Robinson R.G., Coyle J.T., and Sanberg P.R. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants. Eur J Pharmacol 93 (1983) 287-288
81. Clelland C.D., Barker R.A., and Watts C. Cell therapy in Huntington disease. Neurosurg Focus 24 (2008) E9
82. Kim M., Lee S.T., Chu K., and Kim S.U. Stem cell-based cell therapy for Huntington disease: a review. Neuropathology 28 (2008) 1-9
83. Lee S.T., Chu K., Park J.E., Lee K., Kang L., Kim S.U., et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res 52 (2005) 243-249
84. Kelly C.M., Dunnett S.B., and Rosser A.E. Medium spiny neurons for transplantation in Huntington's disease. Biochem Soc Trans 37 (2009) 323-328
85. Emerich D.F. Sertoli cell grafts for Huntington's disease. An opinion. Neurotox Res 5 (2004) 567
86. Fernandez-Espejo E., Armengol J.A., Flores J.A., Galan-Rodriguez B., and Ramiro S. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease. Brain Res Brain Res Rev 49 (2005) 343-354
87. Madrazo I., Drucker-Colin R., Diaz V., Martinez-Mata J., Torres C., and Becerril J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 316 (1987) 831-834
88. Hurtig H., Joyce J., Sladek Jr. J.R., and Trojanowski J.Q. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 25 (1989) 607-614
89. Drucker-Colin R., Verdugo-Diaz L., Morgado-Valle C., Solis-Maldonado G., Ondarza R., Boll C., et al. Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient. A preliminary report. Arch Med Res 30 (1999) 33-39
90. Zhang L., Castell A., Avila E., Drucker-Colin R., and Escobar A. Immunocytochemical, ultrastructural and neurochemical evidences on synaptogenesis and dopamine release of rat chromaffin cells co-cultured with striatal neurons. J Neuropathol Exp Neurol 59 (2000) 170-174
91. Pawelek J.M., and Korner A.M. The biosynthesis of mammalian melanin. Am Sci 70 (1982) 136-145
92. Jorgensen A., Wiencke A.K., la Cour M., Kaestel C.G., Madsen H.O., Hamann S., et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 39 (1998) 1590-1599
93. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
94. Lescaudron L., Unni D., and Dunbar G.L. Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes. Int J Neurosci 113 (2003) 945-956
95. Amin E.M., Reza B.A., Morteza B.R., Maryam M.M., Ali M., and Zeinab N. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res 30 (2008) 1086-1090
96. Edalatmanesh M.A., Matin M.M., Neshati Z., Bahrami A.R., and Kheirabadi M. Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res (2009)
97. Dunbar G.L., Sandstrom M.I., Rossignol J., and Lescaudron L. Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev 5 (2006) 63-79
98. Bantubungi K., Blum D., Cuvelier L., Wislet-Gendebien S., Rogister B., Brouillet E., et al. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol Cell Neurosci 37 (2008) 454-470
99. Zhang Z., Wang X., and Wang S. Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease. In Vitro Cell Dev Biol Anim 44 (2008) 169-177
100. Barzilay R., Kan I., Ben-Zur T., Bulvik S., Melamed E., and Offen D. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev 17 (2008) 547-554
101. Trzaska K.A., Kuzhikandathil E.V., and Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25 (2007) 2797-2808
102. Li Y., Chen J., Wang L., Zhang L., Lu M., and Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316 (2001) 67-70
103. Levy Y.S., Bahat-Stroomza M., Barzilay R., Burshtein A., Bulvik S., Barhum Y., et al. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 10 (2008) 340-352
104. Bouchez G., Sensebe L., Vourc'h P., Garreau L., Bodard S., Rico A., et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int (2008)
105. McCoy M.K., Martinez T.N., Ruhn K.A., Wrage P.C., Keefer E.W., Botterman B.R., et al. Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. Exp Neurol 210 (2008) 14-29
106. Sadan O., Bahat-Stromza M., Barhum Y., Levy Y.S., Pisnevsky A., Peretz H., et al. Protective effects of neurotrophic factors secreting cells in a 6OHDA rat model of Parkinson disease. Stem Cells Dev (2009)
107. Kim Y.J., Park H.J., Lee G., Bang O.Y., Ahn Y.H., Joe E., et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia (2008)
108. Bahat-Stroomza M., Barhum Y., Levy Y.S., Karpov O., Bulvik S., Melamed E., et al. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J Mol Neurosci 39 (2009) 199-210
109. Vazey E.M., Chen K., Hughes S.M., and Connor B. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol 199 (2006) 384-396
110. Levesque M.F. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson's disease: five-year post-operative outcome. Open Stem Cell J 1 (2009) 20-29
111. Kim H., Kim H.W., and Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials 24 (2003) 4671-4679
112. Richardson S.M., Curran J.M., Chen R., Vaughan-Thomas A., Hunt J.A., Freemont A.J., et al. The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-l-lactic acid (PLLA) scaffolds. Biomaterials 27 (2006) 4069-4078
113. Menei P., Montero-Menei C., Venier M.C., and Benoit J.P. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin Drug Deliv 2 (2005) 363-376
114. Seidlits S.K., Lee J.Y., and Schmidt C.E. Nanostructured scaffolds for neural applications. Nanomed 3 (2008) 183-199
115. Potter W., Kalil R.E., and Kao W.J. Biomimetic material systems for neural progenitor cell-based therapy. Front Biosci 13 (2008) 806-821
116. Dalton P.D., and Mey J. Neural interactions with materials. Front Biosci 14 (2009) 769-795
117. Namba R.M., Cole A.A., Bjugstad K.B., and Mahoney M.J. Development of porous PEG hydrogels that enable efficient, uniform cell-seeding and permit early neural process extension. Acta Biomater (2009)
118. Yang C.Y., Song B., Ao Y., Nowak A.P., Abelowitz R.B., Korsak R.A., et al. Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system. Biomaterials (2009)
119. Wang T.W., and Spector M. Development of hyaluronic acid-based scaffolds for brain tissue engineering. Acta Biomater (2009)
120. Kim M. Electrostatic crosslinked in situ-forming in vivo scaffold for rat bone marrow mesenchymal stem cells. Tissue Eng Part A (2009)
121. Newman K.D., and McBurney M.W. Poly(d, l lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials 25 (2004) 5763-5771
122. Cao H., Liu T., and Chew S.Y. The application of nanofibrous scaffolds in neural tissue engineering. Adv Drug Deliv Rev (2009)
123. Valmikinathan C.M., Tian J., Wang J., and Yu X. Novel nanofibrous spiral scaffolds for neural tissue engineering. J Neural Eng 5 (2008) 422-432
124. Vert M. Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts. J Mater Sci Mater Med 20 (2009) 437-446
125. Fournier E., Passirani C., Montero-Menei C.N., and Benoit J.P. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials 24 (2003) 3311-3331
126. Laquerriere P., Grandjean-Laquerriere A., Jallot E., Balossier G., Frayssinet P., and Guenounou M. Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro. Biomaterials 24 (2003) 2739-2747
127. Veziers J., Lesourd M., Jollivet C., Montero-Menei C., Benoit J.P., and Menei P. Analysis of brain biocompatibility of drug-releasing biodegradable microspheres by scanning and transmission electron microscopy. J Neurosurg 95 (2001) 489-494
128. Fournier E., Passirani C., Colin N., Sagodira S., Menei P., Benoit J.P., et al. The brain tissue response to biodegradable poly(methylidene malonate 2.1.2)-based microspheres in the rat. Biomaterials 27 (2006) 4963-4974
129. Wong D.Y., Krebsbach P.H., and Hollister S.J. Brain cortex regeneration affected by scaffold architectures. J Neurosurg 109 (2008) 715-722
130. Anselme K. Role of surface topography and surface chemistry in cell/material interfaces. Inserm workshop, St Raphaël, France Tissue engineering: study of the interfaces cell/tissue/material, 2009.
131. Wang W., Itaka K., Ohba S., Nishiyama N., Chung U.I., Yamasaki Y., et al. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials (2009)
132. Blitterswijk D, Stamatialis D, Unadkat H, Papenburg B, Rouwkema J, Truckenmuller R, et al. Materiomics: dealing with the complexity in tissue engineering. Inserm workshop, St Raphaël, France Tissue engineering: study of the interfaces cell/tissue/material.
133. Engler A.J., Sen S., Sweeney H.L., and Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 126 (2006) 677-689
134. Heckmann L., Fiedler J., Mattes T., and Brenner R.E. Mesenchymal progenitor cells communicate via alpha and beta integrins with a three-dimensional collagen type I matrix. Cells Tissues Organs 182 (2006) 143-154
135. Elcin Y.M., Elcin A.E., and Pappas G.D. Functional and morphological characteristics of bovine adrenal chromaffin cells on macroporous poly(d, l-lactide-co-glycolide) scaffolds. Tissue Eng 9 (2003) 1047-1056
136. Saporta S., Borlongan C., Moore J., Mejia-Millan E., Jones S.L., Bonness P., et al. Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplant 6 (1997) 579-584
137. Watts R.L., Raiser C.D., Stover N.P., Cornfeldt M.L., Schweikert A.W., Allen R.C., et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl (2003) 215-227
138. Flores J., Cepeda I.L., Cornfeldt M.L., O'Kusky J.R., and Doudet D.J. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease. J Neuropathol Exp Neurol 66 (2007) 585-596
139. Doudet D.J., Cornfeldt M.L., Honey C.R., Schweikert A.W., and Allen R.C. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp Neurol 189 (2004) 361-368
140. Bakay R.A., Raiser C.D., Stover N.P., Subramanian T., Cornfeldt M.L., Schweikert A.W., et al. Implantation of spheramine in advanced Parkinson's disease (PD). Front Biosci 9 (2004) 592-602
141. Borlongan C.V., Thanos C.G., Skinner S.J., Geaney M., and Emerich D.F. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transpl 16 (2008) 987-992
142. Yamashita T., Deguchi K., Sehara Y., Lukic-Panin V., Zhang H., Kamiya T., et al. Therapeutic strategy for ischemic stroke. Neurochem Res 34 (2009) 707-710
143. Lu D., Mahmood A., Qu C., Hong X., Kaplan D., and Chopp M. Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery 61 (2007) 596-602 [discussion-3]
144. Xiong Y., Qu C., Mahmood A., Liu Z., Ning R., Li Y., et al. Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats. Brain Res (2009)
145. Qu C., Xiong Y., Mahmood A., Kaplan D.L., Goussev A., Ning R., et al. Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds. J Neurosurg (2009)
146. Bosman F.T., and Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol 200 (2003) 423-428
147. Hynes R.O., and Yamada K.M. Fibronectins: multifunctional modular glycoproteins. J Cell Biol 95 (1982) 369-377
148. Powell S.K., and Kleinman H.K. Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 29 (1997) 401-414
149. Engvall E., and Wewer U.M. Domains of laminin. J Cell Biochem 61 (1996) 493-501
150. Durbeej M. Laminins. Cell Tissue Res (2009)
151. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., et al. A simplified laminin nomenclature. Matrix Biol 24 (2005) 326-332
152. Barczyk M., Carracedo S., and Gullberg D. Integrins. Cell Tissue Res (2009)
153. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
154. Ruoslahti E. The RGD story: a personal account. Matrix Biol 22 (2003) 459-465
155. Pollard T.D., and Earnshaw W.C. Cell biology (2004), Saunders-Elsevier p. 813
156. Tate C.C., Tate M.C., and LaPlaca M.C. Fibronectin and laminin increase in the mouse brain after controlled cortical impact injury. J Neurotrauma 24 (2007) 226-230
157. Grimpe B., Dong S., Doller C., Temple K., Malouf A.T., and Silver J. The critical role of basement membrane-independent laminin gamma 1 chain during axon regeneration in the CNS. J Neurosci 22 (2002) 3144-3160
158. Hou S., Xu Q., Tian W., Cui F., Cai Q., Ma J., et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods 148 (2005) 60-70
159. Kearns S.M., Scheffler B., Goetz A.K., Lin D.D., Baker H.D., Roper S.N., et al. A method for a more complete in vitro Parkinson's model: slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit. J Neurosci Methods 157 (2006) 1-9
160. Kearns S.M., Laywell E.D., Kukekov V.K., and Steindler D.A. Extracellular matrix effects on neurosphere cell motility. Exp Neurol 182 (2003) 240-244
161. Tate M.C., Garcia A.J., Keselowsky B.G., Schumm M.A., Archer D.R., and LaPlaca M.C. Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol Cell Neurosci 27 (2004) 22-31
162. Tate M.C., Shear D.A., Hoffman S.W., Stein D.G., Archer D.R., and LaPlaca M.C. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transpl 11 (2002) 283-295
163. Gibson R.M., Craig S.E., Heenan L., Tournier C., and Humphries M.J. Activation of integrin alpha5beta1 delays apoptosis of Ntera2 neuronal cells. Mol Cell Neurosci 28 (2005) 588-598
164. Hall P.E., Lathia J.D., Caldwell M.A., and Ffrench-Constant C. Laminin enhances the growth of human neural stem cells in defined culture media. BMC Neurosci 9 (2008) 71
165. Tate C.C., Shear D.A., Tate M.C., Archer D.R., Stein D.G., and Laplaca M.C. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med (2009)
166. Salinas C.N., and Anseth K.S. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med (2008)
167. Jongpaiboonkit L., King W.J., and Murphy W.L. Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A (2008)
168. D'Ippolito G., Diabira S., Howard G.A., Menei P., Roos B.A., and Schiller P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117 (2004) 2971-2981
169. Karoubi G., Ormiston M.L., Stewart D.J., and Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials (2009)
170. Matsubara T., Tsutsumi S., Pan H., Hiraoka H., Oda R., Nishimura M., et al. A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun 313 (2004) 503-508
171. Prabhakaran M.P., Venugopal J.R., and Ramakrishna S. Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials (2009)
172. Danen E.H., and Yamada K.M. Fibronectin, integrins, and growth control. J Cell Physiol 189 (2001) 1-13
173. Rogers S.L., Letourneau P.C., Palm S.L., McCarthy J., and Furcht L.T. Neurite extension by peripheral and central nervous system neurons in response to substratum-bound fibronectin and laminin. Dev Biol 98 (1983) 212-220
174. Hammarback J.A., Palm S.L., Furcht L.T., and Letourneau P.C. Guidance of neurite outgrowth by pathways of substratum-adsorbed laminin. J Neurosci Res 13 (1985) 213-220
175. Rogers S.L., Palm S.L., Letourneau P.C., Hanlon K., McCarthy J.B., and Furcht L.T. Cell adhesion and neurite extension in response to two proteolytic fragments of laminin. J Neurosci Res 21 (1988) 315-322
176. Rankin S.L., Guy C.S., and Mearow K.M. Neurite outgrowth is enhanced by laminin-mediated downregulation of the low affinity neurotrophin receptor, p75NTR. J Neurochem (2008)
177. Freire E., Gomes F.C., Linden R., Neto V.M., and Coelho-Sampaio T. Structure of laminin substrate modulates cellular signaling for neuritogenesis. J Cell Sci 115 (2002) 4867-4876
178. Shaw D., and Shoichet M.S. Toward spinal cord injury repair strategies: peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J Craniofac Surg 14 (2003) 308-316
179. Yao L., Wang S., Cui W., Sherlock R., O'Connell C., Damodaran G., et al. Effect of functionalized micropatterned PLGA on guided neurite growth. Acta Biomater (2008)
180. Deister C., Aljabari S., and Schmidt C.E. Effects of collagen 1, fibronectin, laminin and hyaluronic acid concentration in multi-component gels on neurite extension. J Biomater Sci Polym Ed 18 (2007) 983-997
181. Koh H.S., Yong T., Chan C.K., and Ramakrishna S. Enhancement of neurite outgrowth using nano-structured scaffolds coupled with laminin. Biomaterials (2008)
182. Docheva D., Popov C., Mutschler W., and Schieker M. Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med 11 (2007) 21-38
183. Klees R.F., Salasznyk R.M., Vandenberg S., Bennett K., and Plopper G.E. Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells. Matrix Biol 26 (2007) 106-114
184. Ho M., Yu D., Davidsion M.C., and Silva G.A. Comparison of standard surface chemistries for culturing mesenchymal stem cells prior to neural differentiation. Biomaterials 27 (2006) 4333-4339
185. Qian L., and Saltzman W.M. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials 25 (2004) 1331-1337
186. Garcia-Fuentes M., Meinel A.J., Hilbe M., Meinel L., and Merkle H.P. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials (2009)
187. Pean J.M., Menei P., Morel O., Montero-Menei C.N., and Benoit J.P. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. Biomaterials 21 (2000) 2097-2101
188. Jollivet C., Aubert-Pouessel A., Clavreul A., Venier-Julienne M.C., Remy S., Montero-Menei C.N., et al. Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease. Biomaterials 25 (2004) 933-942
189. Tatard V.M., Venier-Julienne M.C., Saulnier P., Prechter E., Benoit J.P., Menei P., et al. Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials 26 (2005) 3727-3737
190. Tatard V.M., Venier-Julienne M.C., Benoit J.P., Menei P., and Montero-Menei C.N. In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells. Cell Transpl 13 (2004) 573-583
191. Tatard V.M., Sindji L., Branton J.G., Aubert-Pouessel A., Colleau J., Benoit J.P., et al. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: survival and differentiation of embryonic dopaminergic neurons after grafting in hemiParkinsonian rats. Biomaterials 28 (2007) 1978-1988
192. Nakajima M., Ishimuro T., Kato K., Ko I.K., Hirata I., Arima Y., et al. Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation. Biomaterials 28 (2007) 1048-1060
193. Tucker B.A., Rahimtula M., and Mearow K.M. Integrin activation and neurotrophin signaling cooperate to enhance neurite outgrowth in sensory neurons. J Comp Neurol 486 (2005) 267-280
194. Yiqun Yu S.G., Huang H., and Wen T. Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat stem cells both in vitro and in vivo. J Neurol Sci 255 (2007) 81-86
195. Johnson P.J., Parker S.R., and Sakiyama-Elbert S.E. Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009)
196. Burdick J.A., Ward M., Liang E., Young M.J., and Langer R. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 27 (2006) 452-459
197. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
198. Takahashi K., Okita K., Nakagawa M., and Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2 (2007) 3081-3089
199. Buchholz D.E., Hikita S.T., Rowland T.J., Friedrich A.M., Hinman C.R., Johnson L.V., et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells (2009)
200. Osakada F., Jin Z.B., Hirami Y., Ikeda H., Danjyo T., Watanabe K., et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci (2009)
201. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 105 (2008) 5856-5861
202. Page R.L., Ambady S., Holmes W.F., Vilner L., Kole D., Kashpur O., et al. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells (2009)
203. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324 (2009) 797-801
204. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 (2009) 381-384